Osaic Holdings
AMLX icon

Osaic Holdings’s Amylyx Pharmaceuticals AMLX Stock Holding History

Osaic Holdings’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.67K Sell
483
-45
-9% -$696 ﹤0.01% 6683
2026
Q1 		$7.34K Buy
528
+279
+112% +$3.92K ﹤0.01% 6467
2025
Q4 		$3.01K Buy
249
+24
+11% +$326 ﹤0.01% 6943
2025
Q3 		$3.06K Sell
225
-15
-6% -$141 ﹤0.01% 6994
2025
Q2 		$1.54K Buy
+240
New +$1.17K ﹤0.01% 7029
2025
Q1 		– Sell
-638
Closed -$2.41K – 7435
2024
Q4 		$2.41K Buy
638
+423
+197% +$1.99K ﹤0.01% 6534
2024
Q3 		$696 Buy
+215
New +$483 ﹤0.01% 6945
2024
Q2 		– Sell
-389
Closed -$1.1K – 7404
2024
Q1 		$1.1K Sell
389
-2,761
-88% -$36.1K ﹤0.01% 6657
2023
Q4 		$46.4K Sell
3,150
-22,514
-88% -$345K ﹤0.01% 4955
2023
Q3 		$470K Buy
25,664
+22,142
+629% +$468K ﹤0.01% 3293
2023
Q2 		$76K Buy
3,522
+2,200
+166% +$59.4K ﹤0.01% 4658
2023
Q1 		$38.8K Sell
1,322
-53
-4% -$1.84K ﹤0.01% 5129
2022
Q4 		$51K Sell
1,375
-1,067
-44% -$37.9K ﹤0.01% 4914
2022
Q3 		$69K Buy
2,442
+492
+25% +$12.3K ﹤0.01% 4660
2022
Q2 		$37K Buy
1,950
+550
+39% +$6.53K ﹤0.01% 5172
2022
Q1 		$18K Buy
+1,400
New +$31.6K ﹤0.01% 5748

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Osaic Holdings's AMLX Position: Q2 2026 in Review

Osaic Holdings reduced its Amylyx Pharmaceuticals (AMLX) stake by 8.5% in Q2 2026, selling an estimated $696 and leaving 483 shares worth $8.67K. The position accounts for ﹤0.01% of the portfolio, ranked #6683.

Osaic Holdings first reported a position in AMLX in Q1 2022 and has held it in 16 quarters since. The position peaked at $470K in Q3 2023. 206 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

  • Osaic Holdings held 483 shares of Amylyx Pharmaceuticals worth $8.67K as of Q2 2026.
  • Osaic Holdings sold 45 Amylyx Pharmaceuticals shares in Q2 2026, an estimated $696.
  • Amylyx Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6683 holding.
  • Osaic Holdings first reported a position in Amylyx Pharmaceuticals in Q1 2022 and has held it in 16 quarters since.
  • Osaic Holdings's Amylyx Pharmaceuticals position peaked at $470K in Q3 2023.
  • 206 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.